Canadian Federal Government Extends CERB Payments For 8 More Weeks

As mentioned earlier, the Canadian federal government has been pushing a plan to extend CERB payments for those Canadians that are still out of work following the easing of some restrictions. However on Tuesday, the government’s plans became a reality, and the CERB payments that have serving as a financial lifeline for unemployed Canadians during the coronavirus pandemic.

The CERB payments have been extended for an additional 8 weeks, and as such the benefit will be available for up to a total of 24 weeks for qualifying Canadians. However, there will be some further changes to the eligibility criteria, including encouraging CERB recipients to seek employment as well as utilize the tools offered through Job Bank, which is Canada’s national employment service.

Furthermore, as a move to ensure that Canadians have at their disposal a wider range of financial aid options, the federal government has also extended the Canadian Emergency Wage Subsidy (CEWS) program until August 29, 2020. The CEWS serves as a mode of financial support for Canadian businesses, so that they can continue to keep their employees on payroll as well as re-hire previously laid-off workers as a result of the pandemic.

Information for this briefing was found via the Government of Canada and Statistics Canada. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why Is This $1.5 Billion Gold Story Worth Just $37 Million? | Fredonia Mining PEA

This Copper Stock Exploded Before Anyone Knew the Grade | Decade Resource

Silver Miners Will Crush Gold Miners | Adrian Day

Recommended

Cambria Gold Reverses Course on Mt. Margaret Spinout, Citing Strong Copper Fundamentals

Krait Critical Minerals Closes Acquisition of Nevada Hills Antimony and Its Two Washington Projects

Related News

Revive Therapeutics Signs MOU With Attwill Medical, Manufacturer For Vaxart, For Phase 3 Clinical Trials

Revive Therapeutics (CSE: RVV) (OTC: RVVTF) is one step closer to conducting its phase 3...

Friday, August 14, 2020, 08:50:35 AM

US COVID-19 Death Toll Surpasses 200,000 as Country Braces for Third Wave

As the US rushes to manufacture and approve a coronavirus vaccine, the number of infections...

Tuesday, September 22, 2020, 06:15:30 PM

Gilead’s Antiviral Drug Fails to Treat Coronavirus, Preliminary Study Shows

Gilead Sciences Inc (NASDAQ: GILD) has been running a randomized clinical trial on the experimental...

Thursday, April 23, 2020, 04:16:38 PM

Datametrex AI Secures FDA Authorizations For Two COVID-19 Test Kits

Datametrex AI (TSXV: DM) has expanded its target market for COVID-19 test kits. The company...

Tuesday, June 9, 2020, 08:42:29 AM

Trudeau: Virtual Health Care and Antibody Research to Receive More Than $240M

In a Sunday announcement, Canadian Prime Minister announced the federal government will spend more than...

Sunday, May 3, 2020, 04:00:18 PM